|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Jan 11, 2021
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current assets | ||||||
| Cash and cash equivalents | ||||||
| Restricted cash | ||||||
| Short-term bank deposits, net | ||||||
| Receivables from online payment platforms | ||||||
| Short-term investments, net | ||||||
| Accounts and notes receivable, net | ||||||
| Inventories | ||||||
| Amounts due from related parties | ||||||
| Prepayments and other current assets, net | ||||||
| Total current assets | ||||||
| Non-current assets | ||||||
| Property, equipment and leasehold improvement, net | ||||||
| Intangible assets, net | ||||||
| Long-term investments, net | ||||||
| Deferred tax assets, net | ||||||
| Right-of-use assets, net | ||||||
| Long-term bank deposits, net | ||||||
| Long-term investment securities, net | ||||||
| Goodwill | ||||||
| Other non-current assets, net | ||||||
| Total non-current assets | ||||||
| Total assets | ||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||
| Current liabilities | ||||||
| Accounts and notes payable (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 252,401 and RMB 150,891 as of December 31, 2024 and 2025, respectively) | ||||||
| Contract liabilities (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 1,148 and RMB 567 as of December 31, 2024 and 2025, respectively) | ||||||
| Salary and welfare benefits payable (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 42,785 and RMB 56,203 as of December 31, 2024 and 2025, respectively) | ||||||
| Taxes payable (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 30,720 and RMB 16,203 as of December 31, 2024 and 2025, respectively) | ||||||
| Short-term loans (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 40,000 and RMB 20,000 as of December 31, 2024 and 2025, respectively) | ||||||
| Accrued expenses and other current liabilities (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 92,335 and RM62,535 as of December 31, 2024 and 2025, respectively) | ||||||
| Amounts due to related parties (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 26 and RMB 83 as of December 31, 2024 and 2025, respectively) | ||||||
| Related Party | ||||||
| Dividend payable (including amounts of the consolidated VIE without recourse to the primary beneficiary of nil and nil as of December 31, 2024 and 2025, respectively). | ||||||
| Lease liabilities - current portion (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 9,301 and RMB 9,649 as of December 31, 2024 and 2023, respectively) | ||||||
| Total current liabilities | ||||||
| Non-current liabilities | ||||||
| Deferred tax liabilities (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 3,293 and RMB 3,293 as of December 31, 2024 and 2025, respectively) | ||||||
| Lease liabilities - non-current portion (including amounts of the consolidated VIE without recourse to the primary beneficiary of RMB 4,743 and RMB 25,898 as of December 31, 2024 and 2025, respectively) | ||||||
| Other non-current liabilities | ||||||
| Total non-current liabilities | ||||||
| Total liabilities | ||||||
| Shareholders' equity | ||||||
| Ordinary shares (US$0.00001 par value; 15,000,000,000 shares authorized; 1,570,790,570 shares issued as of December 31, 2024; 1,570,790,570 shares issued as of December 31, 2025) | ||||||
| Treasury stock | ||||||
| Additional paid-in capital | ||||||
| Statutory reserves | ||||||
| Retained earnings | ||||||
| Accumulated other comprehensive income | ||||||
| Total RLX Technology Inc. shareholders' equity | ||||||
| Noncontrolling interests | ||||||
| Total shareholders' equity | ||||||
| Total liabilities and shareholders' equity | ||||||
Loading...
